HC Wainwright & Co. Initiates Coverage On Akerna with Buy Rating, Announces Price Target of $7
HC Wainwright & Co. analyst Scott Buck initiates coverage on Akerna (NASDAQ:KERN) with a Buy rating and announces Price Target of $7.
JMP Securities Initiates Coverage On Confluent with Market Outperform Rating, Announces Price Target of $49
JMP Securities analyst Patrick Walravens initiates coverage on Confluent (NASDAQ:CFLT) with a Market Outperform rating and announces Price Target of $49.
JMP Securities Initiates Coverage On Sprinklr with Market Outperform Rating, Announces Price Target of $27
JMP Securities analyst Patrick Walravens initiates coverage on Sprinklr (NYSE:CXM) with a Market Outperform rating and announces Price Target of $27.
Piper Sandler Initiates Coverage On Monte Rosa Therapeutics with Overweight Rating, Announces Price Target of $40
Piper Sandler analyst Edward Tenthoff initiates coverage on Monte Rosa Therapeutics (NASDAQ:GLUE) with a Overweight rating and announces Price Target of $40.
Piper Sandler Initiates Coverage On Doximity with Overweight Rating, Announces Price Target of $68
Piper Sandler analyst Sean Wieland initiates coverage on Doximity (NYSE:DOCS) with a Overweight rating and announces Price Target of $68.
Goldman Sachs Initiates Coverage On Doximity with Neutral Rating, Announces Price Target of $36
Goldman Sachs analyst Michael Ng initiates coverage on Doximity (NYSE:DOCS) with a Neutral rating and announces Price Target of $36.
Goldman Sachs Initiates Coverage On Bright Health Gr with Buy Rating, Announces Price Target of $36
Goldman Sachs analyst Terence Flynn initiates coverage on Bright Health Gr (NYSE:BHG) with a Buy rating and announces Price Target of $36.
Goldman Sachs Initiates Coverage On Confluent with Neutral Rating, Announces Price Target of $37
Goldman Sachs analyst Kash Rangan initiates coverage on Confluent (NASDAQ:CFLT) with a Neutral rating and announces Price Target of $37.
Stifel Initiates Coverage On Sprinklr with Buy Rating, Announces Price Target of $26
Stifel analyst Tom Roderick initiates coverage on Sprinklr (NYSE:CXM) with a Buy rating and announces Price Target of $26.
Stifel Initiates Coverage On First Advantage with Buy Rating, Announces Price Target of $24
Stifel analyst Shlomo Rosenbaum initiates coverage on First Advantage (NASDAQ:FA) with a Buy rating and announces Price Target of $24.